Kezia Gaitskell

Clinical Non-Stipendiary Lecturer; Academic Clinical Lecturer in Histopathology

Kezia Gaitskell is an Academic Clinical Lecturer in the Nuffield Division of Clinical Laboratory Sciences (NDCLS), where she combines research with clinical training as an honorary registrar in histopathology.

She graduated with distinction from Oxford University Medical School in 2008, and undertook Academic Foundation Training in London, before studying for an MSc in Epidemiology at the London School of Hygiene and Tropical Medicine (graduating with distinction). She worked as a histopathology trainee in London, and completed a DPhil in Population Health in the Oxford University Cancer Epidemiology Unit (funded by Cancer Research UK), before taking up her current post.

Her main research interest is at the junction of epidemiology and pathology, in collaboration with the Nuffield Department of Population Health. For her DPhil, she explored risk factors for ovarian cancer, and their variation by histological type, supervised by Professor Dame Valerie Beral, and Professor Ahmed A. Ahmed. Her current work continues to investigate factors associated with cancer incidence and survival, and how these associations vary by tumour histotype.



‘Merkel cell carcinoma with divergent differentiation’
Journal article
GAITSKELL K. et al, (2019), Clinical and Experimental Dermatology

‘Merkel cell carcinoma with divergent differentiation: two case reports.’
Conference paper
Gaitskell K. and Ibrahim H., (2019), Clin Exp Dermatol

‘Hematological parameters and prevalence of anemia in white and British Indian vegetarians and nonvegetarians in the UK Biobank.’
Journal article
Tong TYN. et al, (2019), Am J Clin Nutr, 110, 461 – 472

‘Haematological parameters and anaemia in white and British Indian meat-eaters and vegetarians in UK Biobank’
Conference paper
Tong TYN. et al, (2019), PROCEEDINGS OF THE NUTRITION SOCIETY, 78, E23 – E23

‘Pre-diagnostic BMI and ovarian cancer survival in the Million Women Study’
Gaitskell K. et al, (2018), BRITISH JOURNAL OF CANCER, 119, 32 – 33

Where Next?